Key result
Pre-eclampsia linked to ~26% higher hypertension risk at 1 year postpartum versus normotensive controls.
Why the study?
To investigate the prevalence of hypertension and cardiovascular dysfunction 1 year postpartum in Black African women who experienced pre-eclampsia in a low-resource setting in Uganda.
Does pre-eclampsia increase the risk of hypertension and cardiovascular dysfunction at 1 year postpartum in Black African women?
Cohort (n=528)
No
Does pre-eclampsia increase the risk of hypertension and cardiovascular dysfunction at 1 year postpartum in Black African women?
Effect estimate: aIRR 1.26 (95% CI 1.16-1.36)
Absolute Event Rate: 36.4% vs 4.5%
p-value: p=< 0.001
Black African women with pre-eclampsia have a significantly higher risk of developing hypertension and adverse cardiovascular markers at 1 year postpartum, highlighting the need for early postpartum monitoring.
Supports postpartum BP monitoring after pre-eclampsia; leaves open causality and generalizability to other populations.
OBJECTIVE: To investigate the prevalence of hypertension and cardiovascular dysfunction 1 year postpartum in Black African women who experienced pre-eclampsia in a low-resource setting in Uganda. DESIGN: Prospective cohort study. SETTING: Tertiary referral hospital in urban Uganda. POPULATION: Pregnant women who developed pre-eclampsia between 2019 and 2021, matched to normotensive controls with maternal and gestational age. METHODS: Sociodemographic, clinical and laboratory data were collected at recruitment and 1 year postpartum. Baseline characteristics and incidence rate ratios were calculated to assess risk factors for developing hypertension. Multivariable conditional Poisson regression adjusted for matched study design was used to analyse outcomes. MAIN OUTCOME MEASURES: The primary outcome was hypertension (≥ 140/≥ 90 mmHg) at 1 year postpartum. Secondary outcomes included aortic pulse wave velocity, left ventricular mass index, and left ventricular ejection fraction at 1 year postpartum. RESULTS: At one-year postpartum, hypertension prevalence was higher among women with pre-eclampsia than controls (36.4% (96/264) versus 4.5% (12/264); aIRR 1.26, 95% CI 1.16-1.36, p < 0.001). Postpartum median aortic pulse wave velocity was increased in women with pre-eclampsia (6.45 ± 0.76 m/s vs. 5.67 ± 0.22 m/s, p < 0.001). Left ventricular mass indexed to body surface area was increased in women with pre-eclampsia (71.7 ± 19.6 g vs. 76.5 ± 23.2 g, p < 0.01). Left ventricular ejection fraction was not influenced by pre-eclampsia (p = 0.35). CONCLUSIONS: In this low-resource setting, black African women with pre-eclampsia had increased cardiovascular risk markers at one year postpartum. Over one-third of women with pre-eclampsia developed hypertension at one year postpartum, emphasising the need for postpartum blood pressure monitoring and early intervention to mitigate long-term cardiovascular risk in this high-risk population.
No takes yet. Share an insight, caveat, or question.
Nakimuli et al. (2025) conducted a cohort in Pre-eclampsia (n=528). Pre-eclampsia vs. Normotensive controls was evaluated on Hypertension (≥ 140/≥ 90 mmHg) at 1 year postpartum (aIRR 1.26, 95% CI 1.16-1.36, p=< 0.001). Pre-eclampsia was associated with a significantly higher prevalence of hypertension at 1 year postpartum compared to normotensive controls (36.4% vs 4.5%; aIRR 1.26; 95% CI 1.16-1.36; p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: